News

Researchers at the University of Tartu found that genetic differences in the CYP2C19 gene significantly affect how people tolerate antidepressants. Slow metabolizers faced 49% higher side effect risk, while ultra-rapid ones had reduced risk.

A team of researchers has identified a potential new strategy to prevent, or even reverse, immune checkpoint inhibitor–induced type 1 diabetes.

A study reveals that reducing the amino acid cysteine triggers fat browning and weight loss. Researchers found calorie restriction lowers cysteine in human fat tissue, while animal models showed dramatic fat loss when cysteine was depleted.

Mayo Clinic researchers examined whether people who simultaneously received both a kidney and stem cell transplant from a closely matched sibling could discontinue all immunosuppressive medications after a year.

Ambroxol – a common cough medicine in Europe – may prevent the progression of dementia in patients with Parkinson's disease, a new trial suggests.

Researchers have created liver tissue that grows its own blood vessels, improving research into hemophilia and liver damage.

New research identifies key genes in "zombie" TB cells resistant to antibiotics, bringing new drugs one step closer.

A surgeon has helped develop and test a first-of-its-kind drug that binds to nerve tissue and fluoresces – emits light – enabling surgeons to better see the nerves they’re trying to work around.

A study found that combining the active ingredient extracted from the traditional Chinese medicine Astragalus membranaceus with the widely used Western drug methotrexate can effectively reduce chronic inflammation in autoimmune diseases.

Scientists have developed mouse models that survive premature death and enable preclinical testing of alternating hemiplegia of childhood, or AHC, a devastating and sometimes fatal neurological disorder that affects about one in a million children.